Dong-A University
Also known as: 9F, DongA University Hospital Department of clinical pharmacology, #26, Daechingongwon-ro, seo-gu, busan, 49201, KOREA | Assistant professor and Chariman, Department of dermatology Dong-A University, College of medicine | Department of Dermatology, College of Medicine, Dong-A University | Dong-A National Univ. Hos. | Donga Univ. | Dong-A University | Dong-A University College of Medicine & Dong-A University Medical Center | Dong-A University Hospital | Dong-A University Hospital, Busan, Republic of Korea | Dong-A university hospital of Korea | Dong-A University Hospital of Korea | Onclogy Division, Dong-A University Hospital | Sung Yong Oh | The Dong-A University Hospital
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2007Last known activity
Jul 1, 2023
Timeline
1940s
- Jan 1, 1946
Dong-A University— Founded
Drugs by trial phase (80 distinct, 71 trials)
Phase 4 (21 own, 0 via acquisition)
Phase 3 (17 own, 0 via acquisition)
Phase 2 (20 own, 0 via acquisition)
Phase 1 (17 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Alzheimer Disease
- Arterial Occlusive Diseases
- Arthritis
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Atrial Fibrillation
- Biliary Tract Neoplasms
- Bowen's Disease
- Carcinoma
- Carcinoma, Squamous Cell
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cerebral Infarction
- Cheilitis
- Coronary Artery Disease
- Coronary Disease
- Diabetes Mellitus
- Dyslipidemias
- Edema
- Epilepsy
- Esophageal Squamous Cell Carcinoma
- Essential Hypertension
- Gastritis
- Hemangiosarcoma
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hiccup
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperplasia
- Hypertension
- Hypertriglyceridemia
- Infarction
- Intermittent Claudication
- Ischemia
- Ischemic Attack, Transient
- Keratosis
- Keratosis, Actinic
- Kidney Diseases
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Large B-Cell, Diffuse
- Macular Edema
- Myocardial Infarction
- Myocardial Ischemia
- Pancreatic Neoplasms
- Peripheral Arterial Disease
- Prostatic Hyperplasia
- Renal Insufficiency, Chronic
- Skin Diseases
- Spondylitis
- Spondylitis, Ankylosing
- ST Elevation Myocardial Infarction
- Stomach Neoplasms
- Stroke
- Syndrome
- Ventricular Remodeling
- Vitamin D Deficiency
Recent trials (50)
- NCT05909826Overall official - principal investigatorPhase 2Jul 1, 2023
- NCT05909826Reponsible party - principal investigatorPhase 2Jul 1, 2023
- NCT05909826Lead sponsorPhase 2Jul 1, 2023
- NCT05378360Overall official - principal investigatorPhase 2May 2, 2022
- NCT05225077Reponsible party - principal investigatorPhase 4Jan 1, 2022
- NCT05210595Overall official - principal investigatorPhase 4Jan 1, 2022
- NCT05225077Lead sponsorPhase 4Jan 1, 2022
- NCT05210595Reponsible party - principal investigatorPhase 4Jan 1, 2022
- NCT05210595Lead sponsorPhase 4Jan 1, 2022
- NCT04755387Reponsible party - principal investigatorPhase 4Feb 15, 2021
- NCT04755387Lead sponsorPhase 4Feb 15, 2021
- NCT04755387Overall official - principal investigatorPhase 4Feb 15, 2021
- NCT04570345Overall official - principal investigatorPhase 4Jan 1, 2021
- NCT04570345Reponsible party - principal investigatorPhase 4Jan 1, 2021
- NCT04570345Lead sponsorPhase 4Jan 1, 2021
Details
- Founded
- Busan, KR Jan 1, 1946
- Last known activity
- Jul 1, 2023